Diane G. Gerst, EVP, QA & Regulatory Affairs at Amphastar Pharmaceuticals, Inc. (AMPH), sold 523 shares at $18.96 ($10K) on 2017-12-12, disclosed to the SEC on 2017-12-14.
Scheduled sale ($10k) by EVP, QA & Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AMPH | SELL | 2022-07-06 | $63K | — | Filing → |
| AMPH | SELL | 2022-07-05 | $180K | — | Filing → |
| AMPH | SELL | 2017-12-19 | $10K | — | Filing → |